Mimedx Group Inc [MDXG] stock is trading at $9.23, up 23.56%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MDXG shares have gain 24.06% over the last week, with a monthly amount glided 57.78%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Mimedx Group Inc [NASDAQ: MDXG] stock has seen the most recent analyst activity on July 02, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $11. Previously, Lake Street started tracking the stock with Buy rating on March 07, 2024, and set its price target to $12. On October 27, 2023, Craig Hallum initiated with a Buy rating and assigned a price target of $12 on the stock. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $7 on October 13, 2022. Northland Capital initiated its recommendation with a Outperform and recommended $23 as its price target on July 26, 2021. H.C. Wainwright started tracking with a Buy rating for this stock on March 19, 2021, and assigned it a price target of $20.
Mimedx Group Inc [MDXG] stock has fluctuated between $5.47 and $9.27 over the past year. Currently, Wall Street analysts expect the stock to reach $10.33 within the next 12 months. Mimedx Group Inc [NASDAQ: MDXG] shares were valued at $9.23 at the most recent close of the market. An investor can expect a potential return of 11.92% based on the average MDXG price forecast.
Analyzing the MDXG fundamentals
Mimedx Group Inc [NASDAQ:MDXG] reported sales of 342.81M for the trailing twelve months, which represents a growth of 2.87%. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.28%. To continue investigating profitability, this company’s Return on Assets is posted at 0.4, Equity is 0.6 and Total Capital is 0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.19 points at the first support level, and at 7.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.79, and for the 2nd resistance point, it is at 10.36.
Ratios To Look Out For
For context, Mimedx Group Inc’s Current Ratio is 4.10. As well, the Quick Ratio is 3.53, while the Cash Ratio is 2.12. Considering the valuation of this stock, the price to sales ratio is 3.96, the price to book ratio is 7.49 and price to earnings (TTM) ratio is 15.77.
Transactions by insiders
Recent insider trading involved GARDNER PHYLLIS, Former Director, that happened on Oct 10 ’24 when 30000.0 shares were purchased. General Counsel and CAO, Hulse William Frank IV completed a deal on Mar 13 ’24 to sell 20381.0 shares. Meanwhile, Chief Operating Officer Whitlow Ricci S sold 15493.0 shares on Feb 16 ’24.
